Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Sphere 3D (ANY) Announces Merger Agreement with Gryphon Digital Mining
-
Form 8-K Cantor Fitzgerald Income For: May 31
-
Cantor Fitzgerald Resumes Tilray (TLRY) at Overweight
-
Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer
-
UPDATE: Cantor Fitzgerald Starts Cutera (CUTR) at Overweight
-
Brainsway (BWAY) PT Raised to $15 at Cantor Fitzgerald on OCD Reimbursement Success
-
Canopy Growth (WEED:CN) (CGC) PT Lowered to Cdn$30.50 at Cantor Fitzgerald
-
Searchlight Capital Partners to Acquire Majority Stake in Care Advantage
-
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10.8 Million into Dragon SPAC
-
Napo EU S.p.A., Jaguar Health’s Italian Subsidiary, Provides Updates on Plans to Pursue Conditional Marketing Authorization in the EU
-
UPDATE: Cantor Fitzgerald Starts Seelos Therapeutics (SEEL) at Overweight
-
Fire & Flower Holdings Corp. (FFLWF) Announces Participation at June Investor Conferences
-
Khiron Announces Upcoming Investor Events and Grant of Options and Restricted Share Units
-
Aurora Cannabis to Participate in Three Upcoming Virtual Investor Conferences
-
UPDATE: Cantor Fitzgerald Starts Harpoon Therapeutics (HARP) at Overweight
-
eFFECTOR Therapeutics and Locust Walk Acquisition (LWAC) Announce Merger Agreement
-
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
-
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
-
Ayr Strategies (AYRWF) PT Lowered to $33.50 at Cantor Fitzgerald
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $210 at Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Canada Nickel Company Inc (CNC:CN) (CNIKF) to Buy, After Crawford Nickel Project PEA Released
-
BGC Partners (BGCP) to Sell its Insurance Brokerage Business to The Ardonagh Group for $500 Million
-
BGC Announces Agreement to Sell its Insurance Brokerage Business to The Ardonagh Group for $500 Million
-
Cantor Fitzgerald Starts Chemomab Therapeutics (CMMB) at Overweight
-
Walker & Dunlop Expands New York City Capital Markets Team with Two New Hires
-
Form POS AM Cantor Fitzgerald Income
-
Gryphon Mining Releases New Op-Ed on Crypto and Clean Energy
-
Canopy Growth Corp (WEED:CN) (CGC) PT Lowered to Cdn$32 at Cantor Fitzgerald
-
Small-Cap & Penny Stocks To Watch In May Hitting It Big In 2021
-
Tribe Capital Growth Corp I Announces the Separate Trading of its Class A Common Stock and Warrants
-
TerrAscend Corp. (TRSSF) PT Lowered to $15.50 at Cantor Fitzgerald
-
Form 424B3 Cantor Fitzgerald Income
-
Orion Biotech Opportunities Corp. Announces Closing of $200 Million Initial Public Offering of Securities
-
Gryphon Digital Mining Has Signed Crypto Climate Accord
-
Form 10-Q Cantor Fitzgerald Income For: Mar 31
-
PAVmed Provides Business Update and First Quarter 2021 Financial Results
-
PAVmed Provides Business Update and First Quarter 2021 Financial Results
-
Companies with NDRs 5/14
-
Trulieve Cannabis Corp (TCNNF) PT Lowered to $71 at Cantor Fitzgerald
-
Alexco Resource Corp (AXU:CN) (AXU) PT Raised to Cdn$4 at Cantor Fitzgerald, Following Earnings
-
Computer Programs and Systems (CPSI) PT Raised to $37 at Cantor Fitzgerald
-
Heron Therapeutics (HRTX) Approval 'Positive, Even Without The Cherry on Top' - Cantor Fitzgerald
-
Insmed Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes and Full Exercise of Underwriters' Options to Purchase Additional Shares and Notes
-
AEye to Host Virtual Investor Day on June 23, 2021
-
Westwater Resources Announces First Quarter March 31, 2021 Results
-
AEye Attracts World-Class Talent to Board in Preparation for Listing on Nasdaq in Q3
-
Orion Biotech Opportunities Corp. (ORIA) Prices 20M Unit IPO at $10/Unit
-
Orion Biotech Opportunities Corp. Announces Pricing of $200,000,000 Initial Public Offering
-
Orchid Island Capital Announces May 2021 Monthly Dividend and April 30, 2021 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Reiterates Overweight $10 PT on Mustang Bio (MBIO)

